Anhui Huaren Health Pharmaceutical Co., Ltd. (SHE:301408)
China · Delayed Price · Currency is CNY 13.96
+0.18 (1.31%)
Oct 28, 2026, 4:00 PM EDT
SHE:301408 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 250.17 | 191.35 | 137.7 | 114.67 | 160.78 | 69.73 |
Depreciation & Amortization | 334.92 | 335.39 | 292.42 | 208.75 | 164.52 | 160.66 |
Other Amortization | 30.64 | 30.16 | 23.73 | 31.19 | 53.35 | 55.68 |
Loss (Gain) From Sale of Assets | -3.74 | -3.74 | -2.72 | -1.04 | -0.61 | -0.19 |
Asset Writedown & Restructuring Costs | 72.16 | 72.16 | 17.21 | -0 | 0.01 | -2.72 |
Loss (Gain) From Sale of Investments | -5.03 | -5.03 | -1.62 | -0.8 | -0.81 | -0.83 |
Provision & Write-off of Bad Debts | 14.73 | 14.73 | -0.08 | 2.26 | 1.03 | 4.39 |
Other Operating Activities | 57.06 | 64.17 | 63.02 | 42.74 | 34.81 | 26.46 |
Change in Accounts Receivable | -192.25 | -192.25 | 13.1 | -342.08 | -409.81 | -133.86 |
Change in Inventory | -97.18 | -97.18 | -17.15 | -179.11 | -113.01 | -131.01 |
Change in Accounts Payable | 435.3 | 435.3 | 50.72 | 263.8 | 288.64 | 100.41 |
Change in Other Net Operating Assets | - | - | - | - | 1.7 | 0.25 |
Operating Cash Flow | 888.89 | 837.18 | 571.76 | 131.37 | 173.84 | 140.82 |
Operating Cash Flow Growth | 15.75% | 46.42% | 335.22% | -24.43% | 23.45% | 380.05% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Capital Expenditures | -137.94 | -155.42 | -163.42 | -221.01 | -104.77 | -33.91 |
Sale of Property, Plant & Equipment | 0.36 | 0.43 | 2.2 | 5.65 | 0.5 | 0 |
Cash Acquisitions | -13.89 | -488.35 | -329.33 | -508.68 | -3.49 | -37.54 |
Divestitures | -0 | -0 | - | - | - | - |
Investment in Securities | -89.02 | -11.83 | -1.83 | -82.92 | -16.77 | 17.11 |
Other Investing Activities | -2.42 | 8.02 | 5.44 | 1.14 | -5.43 | 14.25 |
Investing Cash Flow | -242.9 | -647.15 | -486.95 | -805.82 | -129.96 | -40.09 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Long-Term Debt Issued | - | 734.35 | 509.49 | 885.56 | 341.9 | 160.76 |
Total Debt Issued | 1,072 | 734.35 | 509.49 | 885.56 | 341.9 | 160.76 |
Long-Term Debt Repaid | - | -826.54 | -850.95 | -605 | -302.86 | -279.04 |
Lease Payments | -309.86 | -309.86 | -274.19 | -212.53 | -170.42 | -158.04 |
Total Debt Repaid | -915.96 | -826.54 | -850.95 | -605 | -302.86 | -279.04 |
Net Debt Issued (Repaid) | 156.11 | -92.19 | -341.45 | 280.57 | 39.05 | -118.28 |
Issuance of Common Stock | 0.07 | - | - | 974.56 | - | - |
Common Dividends Paid | -59.38 | -56.75 | -55.98 | -14.69 | -4.13 | -4.34 |
Other Financing Activities | -647.08 | -95.58 | 41.67 | -104.17 | -2.76 | 19 |
Financing Cash Flow | -550.35 | -244.52 | -355.77 | 1,136 | 32.15 | -103.62 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Foreign Exchange Rate Adjustments | -0.47 | -0.13 | 0.11 | 0.1 | - | - |
Net Cash Flow | 95.16 | -54.62 | -270.84 | 461.92 | 76.04 | -2.89 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Free Cash Flow | 750.95 | 681.76 | 408.33 | -89.64 | 69.07 | 106.91 |
Free Cash Flow Growth | 17.76% | 66.96% | - | - | -35.40% | - |
Free Cash Flow Margin | 12.71% | 12.43% | 9.01% | -2.36% | 2.12% | 4.57% |
Free Cash Flow Per Share | 1.88 | 1.71 | 1.01 | -0.23 | 0.20 | 0.32 |
Levered Free Cash Flow | - | 510.49 | 461.77 | 221.36 | 132.02 | 228.23 |
Unlevered Free Cash Flow | - | 529.38 | 481.86 | 239.52 | 146.63 | 243.24 |
Free Cash Flow After Leases | 441.1 | 371.91 | 134.15 | -302.17 | -101.35 | -51.13 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash Interest Paid | 0 | 0 | 0 | 0 | - | - |
Cash Income Tax Paid | 347.46 | 221.55 | 210.18 | 186.5 | 151.26 | 106.53 |
Change in Working Capital | 137.98 | 137.98 | 42.09 | -266.37 | -239.23 | -172.35 |